华润医药(03320.HK)附属完成发行11亿元公司债

Core Viewpoint - China Resources Pharmaceutical (03320.HK) has successfully completed the public issuance of the second phase of its 2025 corporate bonds, raising a total principal amount of RMB 1.1 billion with a three-year term and an annual coupon rate of 1.78% [1] Group 1 - The total principal amount of the second phase of the 2025 corporate bonds issued is RMB 1.1 billion [1] - The bonds have a maturity period of three years and an annual interest rate of 1.78% [1] - The net proceeds from the bond issuance will be used for productive expenditures, including debt repayment, working capital supplementation, project development and operational expenses, investments related to technological innovation, and other uses compliant with applicable laws and regulations [1]